Blood Pressure and Cognitive Outcome

Current Cardiovascular Risk Reports

Volumn 4, Issue 5, 2010, Pages 369-375

  Mackey, Rachel H ^a   Kuller, Lewis H ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Blood pressure; Cognitive outcomes; Dementia; Hypertension

Indexed keywords

EID: 80052333559     PISSN: 19329520     EISSN: 19329563     Source Type: Journal    
DOI: 10.1007/s12170-010-0122-8     Document Type: Review

References (56)

1. Jalbert JJ, Daiello LA, Lapane KL: Dementia of the Alzheimer type. Epidemiol Rev 2008, 30: 15-34.
2. •• Staessen JA, Richart T, Birkenhager WH: Less atherosclerosis and lower blood pressure for a meaningful life perspective with more brain. Hypertension 2007, 49: 389-400. This excellent review summarizes epidemiologic studies of BP and cognitive function in cross-sectional and longitudinal observational studies as well as in clinical trials.
3. Qiu C, Winblad B, Fratiglioni L: The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 2005, 4: 487-499.
4. Birns J, Kalra L: Cognitive function and hypertension. J Hum Hypertens 2009, 23: 86-96.
5. Euser SM, van Bemmel T, Schram MT, et al.: The effect of age on the association between blood pressure and cognitive function later in life. J Am Geriatr Soc 2009, 57: 1232-1237.
6. • Stewart R, Xue QL, Masaki K, et al.: Change in blood pressure and incident dementia: a 32-year prospective study. Hypertension 2009, 54: 233-240. This study demonstrates the longitudinal relationship of BP to incident dementia among men over 32 years of follow-up, showing that men who eventually developed dementia had a greater increase in SBP from mid-life to late life followed by a greater decrease in SBP over an approximately 6-year period prior to dementia diagnosis, compared with men who did not develop dementia.
7. Duron E, Rigaud AS, Dubail D, et al.: Effects of antihypertensive therapy on cognitive decline in Alzheimer's disease. Am J Hypertens 2009, 22: 1020-1024.
8. Hernan MA, Alonso A, Logroscino G: Cigarette smoking and dementia: potential selection bias in the elderly. Epidemiology 2008, 19: 448-450.
9. Euser SM, Schram MT, Hofman A, et al.: Measuring cognitive function with age: the influence of selection by health and survival. Epidemiology 2008, 19: 440-447.
10. Terrera GM, Brayne C, Matthews F: One size fits all? Why we need more sophisticated analytical methods in the explanation of trajectories of cognition in older age and their potential risk factors. Int Psychogeriatr 2010, 22: 291-299.
11. • Lucas SJ, Tzeng YC, Galvin SD, et al.: Influence of changes in blood pressure on cerebral perfusion and oxygenation. Hypertension 2010, 55: 698-705. Contrary to belief that CBF was regulated to be independent of changes in systemic mean arterial pressure across a range of normal pressure, this study showed that CBF does change in response to changes in mean arterial pressure. The study results also found that cerebral oxygenation was higher with hypotension and lower CBF, and lower with hypertension and higher CBF, suggesting a mechanism linking hypertension and cerebral ischemia.
12. Dai W, Lopez OL, Carmichael OT, et al.: Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging. Radiology 2009, 250: 856-866.
13. Chao LL, Buckley ST, Kornak J, et al.: ASL perfusion MRI predicts cognitive decline and conversion from MCI to dementia. Alzheimer Dis Assoc Disord 2010, 24: 19-27.
14. Efimova IY, Efimova NY, Triss SV, et al.: Brain perfusion and cognitive function changes in hypertensive patients. Hypertens Res 2008, 31: 673-678.
15. Dai W, Lopez OL, Carmichael OT, et al.: Abnormal regional cerebral blood flow in cognitively normal elderly subjects with hypertension. Stroke 2008, 39: 349-354.
16. Haag MD, Hofman A, Koudstaal PJ, et al.: Duration of antihypertensive drug use and risk of dementia: A prospective cohort study. Neurology 2009, 72: 1727-1734.
17. Hoffman LB, Schmeidler J, Lesser GT, et al.: Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons. Neurology 2009, 72: 1720-1726.
18. Wang LY, Larson EB, Sonnen JA, et al.: Blood pressure and brain injury in older adults: findings from a community-based autopsy study. J Am Geriatr Soc 2009, 57: 1975-1981.
19. Birns J, Morris R, Donaldson N, et al.: The effects of blood pressure reduction on cognitive function: a review of effects based on pooled data from clinical trials. J Hypertens 2006, 24: 1907-1914.
20. Duron E, Hanon O: Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag 2008, 4: 363-381.
21. McGuinness B, Todd S, Passmore P, et al.: Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst Rev 2009, CD004034.
22. Beckett NS, Peters R, Fletcher AE, et al.: Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008, 358: 1887-1898.
23. Peters R, Beckett N, Forette F, et al.: Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol 2008, 7: 683-689.
24. •• Mitchell GF: Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage. J Appl Physiol 2008, 105: 1652-1660. This article reviews current evidence and the mechanisms by which arterial stiffening contributes to microvascular damage of the brain and kidney.
25. Sink KM, Leng X, Williamson J, et al.: Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study. Arch Intern Med 2009, 169: 1195-1202.
26. • Dufouil C, Godin O, Chalmers J, et al.: Severe cerebral white matter hyperintensities predict severe cognitive decline in patients with cerebrovascular disease history. Stroke 2009, 40: 2219-2221. This recent study showed that baseline WMD predicts cognitive decline.
27. Ikram MA, Vrooman HA, Vernooij MW, et al.: Brain tissue volumes in relation to cognitive function and risk of dementia. Neurobiol Aging 2010, 31: 378-386.
28. • Inzitari D, Pracucci G, Poggesi A, et al.: Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort. BMJ 2009, 339: b2477. This study showed that cognitive decline and global functional decline paralleled worsening of WMD, supporting a causal relationship.
29. Kuller LH, Margolis KL, Gaussoin SA, et al.: Relationship of hypertension, blood pressure, and blood pressure control with white matter abnormalities in the Women's Health Initiative Memory Study (WHIMS)-MRI trial. J Clin Hypertens (Greenwich) 2010, 12: 203-212.
30. Gottesman RF, Coresh J, Catellier DJ, et al.: Blood pressure and white-matter disease progression in a biethnic cohort: Atherosclerosis Risk in Communities (ARIC) study. Stroke 2010, 41: 3-8.
31. Dufouil C, Chalmers J, Coskun O, et al.: Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation 2005, 112: 1644-1650.
32. Firbank MJ, Wiseman RM, Burton EJ, et al.: Brain atrophy and white matter hyperintensity change in older adults and relationship to blood pressure. Brain atrophy, WMH change and blood pressure. J Neurol 2007, 254: 713-721.
33. Savva GM, Stephan BC: Epidemiological studies of the effect of stroke on incident dementia: a systematic review. Stroke 2010, 41: e41-e46.
34. Newman AB, Fitzpatrick AL, Lopez O, et al.: Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. J Am Geriatr Soc 2005, 53: 1101-1107.
35. Rosano C, Naydeck B, Kuller LH, et al.: Coronary artery calcium: associations with brain magnetic resonance imaging abnormalities and cognitive status. J Am Geriatr Soc 2005, 53: 609-615.
36. Romero JR, Beiser A, Seshadri S, et al.: Carotid artery atherosclerosis, MRI indices of brain ischemia, aging, and cognitive impairment: the Framingham study. Stroke 2009, 40: 1590-1596.
37. Sojkova J, Najjar SS, Beason-Held LL, et al.: Intima-media thickness and regional cerebral blood flow in older adults. Stroke 2010, 41: 273-279.
38. Waldstein SR, Rice SC, Thayer JF, et al.: Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore Longitudinal Study of Aging. Hypertension 2008, 51: 99-104.
39. Elias MF, Robbins MA, Budge MM, et al.: Arterial pulse wave velocity and cognition with advancing age. Hypertension 2009, 53: 668-673.
40. Buchman AS, Tanne D, Boyle PA, et al.: Kidney function is associated with the rate of cognitive decline in the elderly. Neurology 2009, 73: 920-927.
41. Khatri M, Wright CB, Nickolas TL, et al.: Chronic kidney disease is associated with white matter hyperintensity volume: the Northern Manhattan Study (NOMAS). Stroke 2007, 38: 3121-3126.
42. Weiner DE, Bartolomei K, Scott T, et al.: Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders. Am J Kidney Dis 2009, 53: 438-447.
43. Petersen RC, Roberts RO, Knopman DS, et al.: Mild cognitive impairment: ten years later. Arch Neurol 2009, 66: 1447-1455.
44. Rosano C, Sigurdsson S, Siggeirsdottir K, et al.: Magnetization transfer imaging, white matter hyperintensities, brain atrophy and slower gait in older men and women. Neurobiol Aging 2008 (in press).
45. Vernooij MW, Ikram MA, Vrooman HA, et al.: White matter microstructural integrity and cognitive function in a general elderly population. Arch Gen Psychiatry 2009, 66: 545-553.
46. • Jack CR Jr, Lowe VJ, Weigand SD, et al.: Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain 2009, 132: 1355-1365. Using serial PIB-PET imaging on healthy, cognitively normal controls, participants with amnestic mild cognitive impairment, and participants with AD, this small study found that cognitive decline was more strongly related to neurodegeneration (i. e., MRI-measured cerebral atrophy) than to continued cerebral amyloid deposition.
47. • Rothwell PM: Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet 2010, 375: 938-948. This interesting review highlights the role of BP variability, instability, and episodic hypertension in predicting cardiovascular risk and hypothesizes that it could also increase vascular dementia.
48. Havlik RJ, Foley DJ, Sayer B, et al.: Variability in midlife systolic blood pressure is related to late-life brain white matter lesions: the Honolulu-Asia Aging study. Stroke 2002, 33: 26-30.
49. •• Protogerou A, Blacher J, Stergiou GS, et al.: Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study. J Am Coll Cardiol 2009, 53: 445-451. This article reports that aortic stiffness is a key predictor of SBP control in response to antihypertensive medication.
50. Peralta CA, Shlipak MG, Wassel-Fyr C, et al.: Association of antihypertensive therapy and diastolic hypotension in chronic kidney disease. Hypertension 2007, 50: 474-480.
51. Chobanian AV, Bakris GL, Black HR, et al.: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289: 2560-2572.
52. Guo H, Tabara Y, Igase M, et al.: Abnormal nocturnal blood pressure profile is associated with mild cognitive impairment in the elderly: the J-SHIPP study. Hypertens Res 2010, 33: 32-36.
53. Hajjar I, Zhao P, Alsop D, et al.: Association of blood pressure elevation and nocturnal dipping with brain atrophy, perfusion and functional measures in stroke and nonstroke individuals. Am J Hypertens 2010, 23: 17-23.
54. Nagai M, Hoshide S, Ishikawa J, et al.: Ambulatory blood pressure as an independent determinant of brain atrophy and cognitive function in elderly hypertension. J Hypertens 2008, 26: 1636-1641.
55. • The ACCORD Study Group, Cushman WC, Evans GW, et al.: Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus. N Engl J Med 2010, 362: 1575-1585. This recent study shows that intensive blood pressure reduction (SBP & 120 mm Hg) among high-risk individuals with type 2 diabetes mellitus did not reduce the combined outcome of fatal/nonfatal major cardiovascular events (despite reducing stroke) and caused a higher rate of serious adverse events. The cognitive outcomes in this study have not yet been published.
56. Williamson JD, Miller ME, Bryan RN, et al.: The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): rationale, design, and methods. Am J Cardiol 2007, 99: 112i-122i.